EKBAX
Price
$12.87
Change
+$0.13 (+1.02%)
Updated
Apr 2 closing price
Net Assets
1.46B
RIDAX
Price
$25.33
Change
+$0.07 (+0.28%)
Updated
Apr 2 closing price
Net Assets
128.63B
Ad is loading...

EKBAX vs RIDAX

Header iconEKBAX vs RIDAX Comparison
Open Charts EKBAX vs RIDAXBanner chart's image
Allspring Diversified Cap Bldr A
Price$12.87
Change+$0.13 (+1.02%)
VolumeN/A
Net Assets1.46B
American Funds Income Fund of Amer R1
Price$25.33
Change+$0.07 (+0.28%)
VolumeN/A
Net Assets128.63B
EKBAX vs RIDAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
EKBAX vs. RIDAX commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EKBAX is a Hold and RIDAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RIDAX has more cash in the bank: 129B vs. EKBAX (1.46B). RIDAX pays higher dividends than EKBAX: RIDAX (3.12) vs EKBAX (0.59). EKBAX was incepted earlier than RIDAX: EKBAX (27 years) vs RIDAX (23 years). RIDAX (1.36) is less costly to investors than EKBAX (1.08). RIDAX is a more actively managed with annual turnover of: 92.00 vs. EKBAX (30.00). RIDAX has a lower initial minimum investment than EKBAX: RIDAX (250) vs EKBAX (1000). RIDAX annual gain was more profitable for investors over the last year : 9.37 vs. EKBAX (-2.63). EKBAX return over 5 years is better than : 56.94 vs. RIDAX (48.61).
EKBAXRIDAXEKBAX / RIDAX
Total Expense Ratio1.081.3679%
Annual Report Gross Expense Ratio1.081.3679%
Fund Existence27 years23 years-
Gain YTD-6.4534.998-129%
Front Load6%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.46B129B1%
Annual Yield % from dividends0.593.1219%
Returns for 1 year-2.639.37-28%
Returns for 3 years2.937.7038%
Returns for 5 years56.9448.61117%
Returns for 10 years39.5733.13119%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
QURE10.620.71
+7.16%
uniQure NV
MLTX38.051.70
+4.68%
MoonLake Immunotherapeutics
COYA6.540.23
+3.65%
Coya Therapeutics
SCI81.560.68
+0.84%
Service Corp
XXII1.30-0.21
-13.91%
22nd Century Group Inc